UK Research and Innovation (UKRI) / Milner Therapeutics Institute (University of Cambridge) Royaume-Uni
2026
Informations
A call to collaborate with the Functional Genomics Screening Laboratory (FGSL) to run CRISPR screening projects using complex human in vitro models to understand model biology and enable target identification. Screens are executed by scientists employed at the Milner Therapeutics Institute, with library access provided through arrangements with AstraZeneca and MTI. Financial support for consumables may be available from AstraZeneca or from an MRC screening access fund. Team applications and applications from UK-based industry parties may be considered where space permits.
Avantages
Access to FGSL-run CRISPR screens executed by MTI scientists; access to CRISPR libraries via AstraZeneca/MTI arrangements; potential financial support for consumables.
Conditions d'éligibilité
Applicants must be researchers eligible for MRC funding. Applications from UK-based industry parties and small and medium-sized enterprises may also be considered. Applicants do not need to be funded by MRC to apply.
Candidature
Complete an application form through Connect: Health Tech at the University of Cambridge and email the completed application form to fgslapplications@milner.cam.ac.uk.
Vérifie toujours les informations sur le site officiel avant de postuler. Une erreur ? Dis-le-nous.